[Radiotherapy during pregnancy].

Cancer Radiother

Département d'oncologie-radiothérapie, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris, France; Université Paris-Descartes, Paris-Cité Sorbonne, 12, rue de l'École-de-Médecine, 75006 Paris, France.

Published: September 2016

The diagnostic of cancer during pregnancy is a rare and delicate situation. As the developments of the embryo and the human fetus are extremely sensitive to ionizing radiations, the treatment of these tumors should be discussed. The studies - preclinical and clinical - based mostly on exposure accidents show that subdiaphragmatic treatments are possible during pregnancy. When radiotherapy is used, phantom estimations of the dose to the fetus, confirmed by in vivo measurements are required. Irradiation and imaging techniques should be arranged to decrease as much as possible the dose delivered to the fetus and hold below the threshold of 0.1Gy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canrad.2016.07.024DOI Listing

Publication Analysis

Top Keywords

[radiotherapy pregnancy]
4
pregnancy] diagnostic
4
diagnostic cancer
4
cancer pregnancy
4
pregnancy rare
4
rare delicate
4
delicate situation
4
situation developments
4
developments embryo
4
embryo human
4

Similar Publications

Background: The study demonstrates that pharmacological blockade of type 3 metabotropic glutamate (mGlu3) receptors at the time of tumor induction significantly reduces the incidence of brain gliomas in rats. The overall survival of patients with high-grade brain gliomas is 14-20 months after current multimodal therapy, including surgery, radiotherapy, and adjuvant chemotherapy.

Objective: To demonstrate in this experimental model that pharmacological blockade of group II metabotropic glutamate receptors reduces the incidence of brain tumors induced by prenatal exposure to N- ethyl-N-nitrosourea (ENU) in rats.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the feasibility of fertility preservation (FP) in women with cervix cancer, focusing on long-term reproductive outcomes and overall survival.
  • Conducted at Karolinska University Hospital from 1999 to 2021, it included 91 women, primarily diagnosed at an early cancer stage, with various treatment options offered.
  • After an average of 8.1 years of follow-up, only a small percentage of women achieved live births, highlighting the difficulties and complexities of fertility preservation in this cancer context.
View Article and Find Full Text PDF

Radioiodine treatment in female survivors of pediatric differentiated thyroid carcinoma does not affect future pregnancy rates.

Arch Endocrinol Metab

November 2024

Instituto Nacional de Câncer Departamento de Endocrinologia Oncológica Rio de JaneiroRJ Brasil Departamento de Endocrinologia Oncológica, Instituto Nacional de Câncer (Inca), Rio de Janeiro, RJ, Brasil.

Objective: Patients with pediatric differentiated thyroid carcinoma (DTC) treated with radioiodine (RAI) therapy may experience long-term side effects, such as gonadal dysfunction. Therefore, it is crucial to understand the impact of this therapy on ovarian reserve and future pregnancy rates.

Subjects And Methods: Retrospective analysis of 64 female DTC survivors of childbearing age to assess the risk of infertility due to RAI performed before the age of 19 years.

View Article and Find Full Text PDF
Article Synopsis
  • Differentiated thyroid carcinoma is the most common type of endocrine cancer and has seen a rise in cases over the past 30 years, particularly affecting women, who often undergo total thyroidectomy followed by radioiodine treatment.
  • This study aims to examine the impact of radioiodine therapy on ovarian function by measuring levels of Anti-Müllerian hormone (AMH), which helps assess ovarian reserve in women.
  • Findings show a significant drop in AMH levels shortly after treatment, followed by a gradual increase, indicating that monitoring AMH could aid in creating tailored treatment plans for young women considering pregnancy after thyroid cancer treatment.
View Article and Find Full Text PDF

Striae distensae (SD) are a prevalent dermatological concern of women and approximately 90% of pregnant women experience these stretch marks. Fractional microneedle radiofrequency (FMR) and fractional CO2 laser (FCL) have gained substantial attention in the treatment of SD. In clinical studies, a clear superiority between FMR and FCL treatments is not found due to limited studies and sample sizes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!